Goodsurance

Policy & oversight

Nevada Doctor Indicted in Alleged 95 Million Dollar Medicare Wound Care Fraud

A Henderson physician allegedly billed Medicare for costly skin-graft products applied to patients who did not need them, including people in hospice care, a federal indictment says.

By the Goodsurance editorial teamAugust 11, 2026

A federal grand jury in Nevada indicted Stephen Dubin, a 74-year-old Henderson physician, on August 5 on charges that he billed Medicare more than 95 million dollars for amniotic wound allografts that were medically unnecessary and obtained through illegal kickbacks. Medicare paid more than 54 million dollars based on his claims, according to the Department of Justice. Dubin allegedly applied expensive skin-substitute products to elderly patients without medical justification, including patients enrolled in hospice care. He is charged with one count of conspiracy to commit health care fraud and five counts of health care fraud. Each count carries a potential sentence of up to 10 years in prison if he is convicted. The case is the first brought in Nevada by the National Fraud Enforcement Division's West Coast Health Care Fraud Strike Force, which the Justice Department formed on April 30. Federal attention to skin-substitute billing has grown sharply in 2026. Congress and CMS examined that billing category after Medicare spending on such products topped 14 billion dollars in recent years. Dubin has not been convicted, and the charges are allegations.

In plain words

A doctor in Henderson, Nevada was charged with cheating Medicare. He billed Medicare for expensive wound-covering products that patients did not need. Some patients were in hospice care. He got the products by making illegal payments to others. Medicare paid him 54 million dollars based on those claims. He is charged with fraud but has not been found guilty.

Source: Department of Justice
Read at the source →

More news

Other stories on what is moving in Medicare.

Policy & oversight

OIG: Medicare Improperly Paid 15.2 Million Dollars for Sacroiliac Joint Injections

A new federal audit found that physician billing for lower-back and pelvis pain injections did not meet Medicare coverage and documentation rules, producing millions in improper payments.

August 11, 2026

Policy & oversight

CMS Opens Annual Medicare Compliance Conference to Sharpen Billing Accuracy Across Fee-for-Service

Medicare contractors and program integrity experts gathered in Charlotte this week to train billing professionals on accurate claims submission for Part A, Part B, home health, hospice, and durable medical equipment.

August 11, 2026

Policy & oversight

OIG Found More Than 15 Million Dollars in Medicare Payments Where Emergency Room Billing Codes Were Used at Non-Emergency Sites

A March 2026 federal audit identified improper and potentially improper Medicare payments made when physicians and hospitals used emergency department billing codes for care not actually delivered in an emergency department, and found that Medicare lacked automated safeguards to catch the mismatches.

August 8, 2026

Policy & oversight

Federal Audit Found at Least 4.7 Million Dollars in Medicare Overpayments at an Arkansas Hospital

An OIG audit of Jefferson Regional Medical Center found a high rate of billing errors on claims flagged as elevated risk, producing an estimated 4.7 million dollars in improper Medicare payments. The hospital disputed most of the findings.

August 7, 2026

Policy & oversight

CMS Publishes Plan to Speed Medicare Coverage for Breakthrough Medical Devices

A new pathway would give FDA-cleared breakthrough devices a national Medicare coverage decision within weeks of regulatory approval, rather than waiting years under the standard process.

August 7, 2026

Policy & oversight

Federal Audit Found 97 Cybersecurity Gaps in Medicare Billing Contractors for Fiscal Year 2024, Though the Most Serious Deficiencies Declined

An OIG annual report to Congress found information security deficiencies across all seven Medicare administrative contractors in fiscal year 2024, while noting that high-risk and moderate-risk gaps fell compared with the prior year.

August 6, 2026